Wall Street Journal Enrollment is complete in a 24-week Phase 2b study of VX-509, a selective JAK3 inhibitor, in people with moderate to severe rheumatoid arthritis (RA) receiving methotrexate . The primary endpoints of this study will be measured after 12 weeks of ...
Zenopa The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has endorsed the product for use alone or in combination with methotrexate among active psoriatic arthritis patients whose response to previous non-biological ... and more »
Pharmacy Europe CHMP stated that Ilaris can be given as monotherapy or in combination with methotrexate . "If approved, Ilaris would provide a new treatment option for patients whose choice of therapy has, to date, been very limited," said Timothy Wright, MD, Global ...
DailyFinance Enrollment is complete in a 24-week Phase 2b study of VX-509, a selective JAK3 inhibitor, in people with moderate to severe rheumatoid arthritis (RA) receiving methotrexate . The primary endpoints of this study will be measured after 12 weeks of ... and more »
Monthly Prescribing Reference Simponi Aria (golimumab for infusion; Janssen Biotech) has received approval from the FDA for the treatment of adults with moderately to se...
Fort Mills Times The Company is developing OTREXUP™, a combination product for the delivery of methotrexate using Medi-Jet™ technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis and psoriasis, as well as VIBEX™ QS ... and more »
walkermessenger If these treatment options are still ineffective, medications such as methotrexate , cyclosporin and retinoids can be taken to suppress the immune system. This method also has many side effects, because while the abnormality in the immune system is ...
PR Newswire (press release) ... Johnson) company, announced that the US Food and Drug Administration (FDA) has approved SIMPONI ARIA (golimumab) for infusion for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) in combination with methotrexate . and more »
Forbes Rheumatoid arthritis patients in 1980 essentially only had methotrexate available to them. I would think it unlikely that these patients would say that the new immunology based agents that have brought them great relief are little better than ...
